Nektar Therapeutics (NKTR)
43.58
-3.41
(-7.26%)
USD |
NASDAQ |
Oct 02, 16:00
43.40
-0.18
(-0.41%)
After-Hours: 20:00
Nektar Therapeutics Market Cap : 1.487B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 1.487B |
| October 01, 2026 | 1.604B |
| September 30, 2026 | 2.066B |
| September 29, 2026 | 2.022B |
| September 28, 2026 | 2.061B |
| September 25, 2026 | 1.947B |
| September 24, 2026 | 2.027B |
| September 23, 2026 | 1.968B |
| September 22, 2026 | 2.081B |
| September 21, 2026 | 2.281B |
| September 18, 2026 | 2.290B |
| September 17, 2026 | 2.333B |
| September 16, 2026 | 2.300B |
| September 15, 2026 | 2.274B |
| September 14, 2026 | 2.338B |
| September 11, 2026 | 2.381B |
| September 10, 2026 | 2.411B |
| September 09, 2026 | 2.502B |
| September 08, 2026 | 2.575B |
| September 04, 2026 | 2.532B |
| September 03, 2026 | 2.606B |
| September 02, 2026 | 2.483B |
| September 01, 2026 | 2.449B |
| August 31, 2026 | 2.436B |
| August 28, 2026 | 2.475B |
| Date | Value |
|---|---|
| August 27, 2026 | 2.544B |
| August 26, 2026 | 2.518B |
| August 25, 2026 | 2.558B |
| August 24, 2026 | 2.515B |
| August 21, 2026 | 2.526B |
| August 20, 2026 | 2.544B |
| August 19, 2026 | 2.597B |
| August 18, 2026 | 2.513B |
| August 17, 2026 | 2.480B |
| August 14, 2026 | 2.492B |
| August 13, 2026 | 2.591B |
| August 12, 2026 | 2.595B |
| August 11, 2026 | 2.577B |
| August 10, 2026 | 1.526B |
| August 07, 2026 | 1.559B |
| August 06, 2026 | 1.497B |
| August 05, 2026 | 1.489B |
| August 04, 2026 | 1.483B |
| August 03, 2026 | 1.439B |
| July 31, 2026 | 1.440B |
| July 30, 2026 | 1.456B |
| July 29, 2026 | 1.440B |
| July 28, 2026 | 1.442B |
| July 27, 2026 | 1.454B |
| July 24, 2026 | 1.441B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 1.076T |
| Inovio Pharmaceuticals, Inc. | 95.52M |
| Tonix Pharmaceuticals Holding Corp. | 149.62M |
| Capricor Therapeutics, Inc. | 520.08M |
| Kyntra Bio, Inc. | 25.55M |
Market Cap Related Metrics
| PS Ratio | 19.37 |
| PEG Ratio | -0.0485 |
| Price to Book Value | 1.647 |
| Price | 43.58 |
| Earnings Yield | -15.37% |
| PEGY Ratio | -0.0485 |